UK markets closed
  • NIKKEI 225

    27,402.05
    +55.17 (+0.20%)
     
  • HANG SENG

    21,958.36
    -113.82 (-0.52%)
     
  • CRUDE OIL

    75.85
    -0.56 (-0.73%)
     
  • GOLD FUTURES

    1,927.10
    -15.70 (-0.81%)
     
  • DOW

    34,053.94
    -39.02 (-0.11%)
     
  • BTC-GBP

    19,395.14
    -108.93 (-0.56%)
     
  • CMC Crypto 200

    541.38
    -3.94 (-0.72%)
     
  • ^IXIC

    12,200.82
    +384.50 (+3.25%)
     
  • ^FTAS

    4,302.89
    +50.04 (+1.18%)
     

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors.

While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.

Why Investors Should Pay Attention to This Value Stock

Finding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, and Price/Cash Flow to highlight the most attractive and discounted stocks.

Bayer Aktiengesellschaft (BAYRY)

Headquartered in Leverkusen, Germany, Bayer AG is a life science company with core competencies in the areas of health care and agriculture.

BAYRY is a Zacks Rank #3 (Hold) stock, with a Value Style Score of A and VGM Score of B. Shares are currently trading at a forward P/E of 7X for the current fiscal year compared to the Large Cap Pharmaceuticals industry's P/E of 14.5X. Additionally, BAYRY has a PEG Ratio of 1.2 and a Price/Cash Flow ratio of 5X. Value investors should also note BAYRY's Price/Sales ratio of 1X.

Many value investors pay close attention to a company's earnings as well. For BAYRY, two analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.01 to $2.03 per share for 2022. Per share BAYRY boasts an average earnings surprise of 18.2%.

BAYRY should be on investors' short lists because of its impressive earnings and valuation fundamentals, a good Zacks Rank, and strong Value and VGM Style Scores.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Bayer Aktiengesellschaft (BAYRY) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research